These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12729404)

  • 1. Final height in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the Italian experience.
    Brunelli VL; Russo G; Bertelloni S; Gargantini L; Balducci R; Chiesa L; Livieri C; De Sanctis C; Einaudi S; Virdis R; Saggese G; Chiumello G
    J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():277-83. PubMed ID: 12729404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
    Hauffa BP; Winter A; Stolecke H
    Klin Padiatr; 1997; 209(2):71-7. PubMed ID: 9113619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
    Bonfig W; Bechtold S; Schmidt H; Knorr D; Schwarz HP
    J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final height of patients with classical congenital adrenal hyperplasia.
    Aycan Z; Akbuğa S; Cetinkaya E; Ocal G; Berberoğlu M; Evliyaoğlu O; Adiyaman P
    Turk J Pediatr; 2009; 51(6):539-44. PubMed ID: 20196386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
    Manoli I; Kanaka-Gantenbein Ch; Voutetakis A; Maniati-Christidi M; Dacou-Voutetakis C
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: final height in 27 patients with the classical form].
    Lemos-Marini SH; Guerra-Júnior G; Morcillo AM; Baptista MT; Silva LO; Maciel-Guerra AT
    Arq Bras Endocrinol Metabol; 2005 Dec; 49(6):902-7. PubMed ID: 16544012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting final height in early treated congenital hypothyroid patients.
    Delvecchio M; Salerno M; Acquafredda A; Zecchino C; Fico F; Manca F; Faienza MF; Cavallo L
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):693-7. PubMed ID: 17054475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
    Pijnenburg-Kleizen KJ; Thomas CMG; Otten BJ; Roeleveld N; Claahsen-van der Grinten HL
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1055-1063. PubMed ID: 31573958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis.
    Eugster EA; Dimeglio LA; Wright JC; Freidenberg GR; Seshadri R; Pescovitz OH
    J Pediatr; 2001 Jan; 138(1):26-32. PubMed ID: 11148508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth pattern and final height in 21-hydroxylase deficiency.
    Bajpai A; Pandey RM; Kabra M; Menon PS
    Indian Pediatr; 2007 Oct; 44(10):771-3. PubMed ID: 17998577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
    Bonfig W; Pozza SB; Schmidt H; Pagel P; Knorr D; Schwarz HP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3882-8. PubMed ID: 19622620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
    Hoepffner W; Kaufhold A; Willgerodt H; Keller E
    Horm Res; 2008; 70(1):42-50. PubMed ID: 18493149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term consequences of childhood-onset congenital adrenal hyperplasia.
    White PC; Speiser PW
    Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):273-88. PubMed ID: 12064893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parentally-adjusted deficit of height as a prognostic factor of the effectiveness of growth hormone (GH) therapy in children with GH deficiency.
    Hilczer M; Smyczyńska J; Lewiński A
    Neuro Endocrinol Lett; 2006; 27(1-2):149-52. PubMed ID: 16648787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
    Bomberg EM; Addo OY; Kyllo J; Gonzalez-Bolanos MT; Ltief AM; Pittock S; Himes JH; Miller BS; Sarafoglou K
    J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [11beta-hydroxylase deficiency: improvement of final height with growth hormone and gonadotropin-releasing hormone analog].
    Orío Hernández M; Yebra Yebra J; Bezanilla López C; Gracia Bouthelier R
    An Pediatr (Barc); 2007 Aug; 67(2):153-6. PubMed ID: 17692261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.
    Van der Kamp HJ; Otten BJ; Buitenweg N; De Muinck Keizer-Schrama SM; Oostdijk W; Jansen M; Delemarre-de Waal HA; Vulsma T; Wit JM
    Arch Dis Child; 2002 Aug; 87(2):139-44. PubMed ID: 12138066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and Treatment in Congenital Adrenal Hyperplasia: An Observational Study from Diagnosis to Final Height.
    Gidlöf S; Hogling DE; Lönnberg H; Ritzén M; Lajic S; Nordenström A
    Horm Res Paediatr; 2024; 97(5):445-455. PubMed ID: 38016434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Trinh L; Nimkarn S; New MI; Lin-Su K
    J Pediatr Endocrinol Metab; 2007 Aug; 20(8):883-91. PubMed ID: 17937061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.